Clinical Trial Update: Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating intravitreal 4D-110 in patients with choroideremia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroideremia

Drugs mentioned

• 4D-110

Snippet

Sponsor: 4D Molecular Therapeutics | Conditions: Choroideremia | Phase 1 | Status: ACTIVE_NOT_RECRUITING